|
|
Post by otherottawaguy on Feb 26, 2019 12:27:53 GMT -5
Did they announce any details (anywhere) as to location in NY and/or date-time of the event?
OOG
|
|
|
|
Post by kc on Feb 26, 2019 12:34:35 GMT -5
It's a good place as it might give MannKind some visibility with NYC based analyst attending. There is a perceived benefit to having the meeting there. What that benefit is only management knows.
|
|
|
|
Post by mango on Feb 26, 2019 12:38:05 GMT -5
It's gonna be in NYC?
|
|
|
|
Post by centralcoastinvestor on Feb 26, 2019 12:40:52 GMT -5
I won’t be making NYC. Unless of course the share price rockets between now and then. Hope burns eternal.
|
|
|
|
Post by #NoMoreNeedles on Feb 26, 2019 12:53:45 GMT -5
BTIG is in NYC
|
|
|
|
Post by goyocafe on Feb 26, 2019 14:07:40 GMT -5
I'm waiting for the proxy. Probably going to see a request for more authorized shares.  |
|
|
|
Post by Thundersnow on Feb 26, 2019 14:15:44 GMT -5
Did they announce any details (anywhere) as to location in NY and/or date-time of the event? OOG TBD - It's Pending. Smart move to be close to Wall Street. No need to tour facility. It's worthless. |
|
|
|
Post by barnstormer on Feb 26, 2019 14:17:26 GMT -5
I'm waiting for the proxy. Probably going to see a request for more authorized shares. You know it brother. |
|
|
|
Post by peppy on Feb 26, 2019 15:58:49 GMT -5
Did they announce any details (anywhere) as to location in NY and/or date-time of the event? OOG annual meeting 5/14 - in NYC from the shout box. |
|
|
|
Post by morfu on Feb 26, 2019 22:13:07 GMT -5
Skimming through the transscript looking for an explanation for a very particular question..
MC: ".. We continue to solidify our institutional shareholders base and regain the confidence of Wall Street. .." "..Our financial positions has significantly been enhanced through our receipt of $45 million with the UT collaboration agreement. Our $40 million public offering... And we ended 2018 with $72 million in cash.." "..Some of the first ones to expect will be the achievement of our first milestone United Therapeutics. We anticipate this being completed, hopefully by the end of Q1.
We have multiple data publications coming out around Hypoglycemia safety and efficacy. We expect to complete pediatric cohort 2 and progress cohort 3. We expect Brazil
approval sometime during late Q1 or Q2.."
".. we continue to accelerate sales and will continue to make efforts that are in the best interest to shareholders.."
Mike, why did you give away 20% if the shares? Given in how you got us there, it is bad to have the greatest amount of cash and not debt in the current situation!
Regardless what you said, that was NOT in the interest of the shareholders! Still there is no explanation for it! The 40 Million you got for it will be meaningless small very soon.. but any future shareholder value as you call it will only be 80%..
|
|
|
|
Post by peppy on Feb 26, 2019 22:21:49 GMT -5
Skimming through the transscript looking for an explanation for a very particular question..
MC: ".. We continue to solidify our institutional shareholders base and regain the confidence of Wall Street. .." "..Our financial positions has significantly been enhanced through our receipt of $45 million with the UT collaboration agreement. Our $40 million public offering... And we ended 2018 with $72 million in cash.." "..Some of the first ones to expect will be the achievement of our first milestone United Therapeutics. We anticipate this being completed, hopefully by the end of Q1.
We have multiple data publications coming out around Hypoglycemia safety and efficacy. We expect to complete pediatric cohort 2 and progress cohort 3. We expect Brazil
approval sometime during late Q1 or Q2.."
".. we continue to accelerate sales and will continue to make efforts that are in the best interest to shareholders.."
Mike, why did you give away 20% if the shares? Given in how you got us there, it is bad to have the greatest amount of cash and not debt in the current situation!
Regardless what you said, that was NOT in the interest of the shareholders! Still there is no explanation for it! The 40 Million you got for it will be meaningless small very soon.. but any future shareholder value as you call it will only be 80%..
Morfu, the debt:cash explanation, something about Deerfield and the Danbury facility. The facility is collateral. Pay off Deerfield and the facility could be used as collateral? Not sure, just throwing it out in the atmosphere. More knowledge people..... please comment if I am missing the mark. |
|
|
|
Post by sportsrancho on Feb 26, 2019 23:43:28 GMT -5
That may be it.
|
|
|
|
Post by Thundersnow on Feb 27, 2019 1:14:29 GMT -5
I'm waiting for the proxy. Probably going to see a request for more authorized shares. You know it brother. I doubt it. They will have 2 sets of warrants plus UTHR Milestones and possible new partner(s) for their molecules. MNKD is set until 2021 at a minimum. |
|
|
|
Post by Thundersnow on Feb 27, 2019 1:18:49 GMT -5
Skimming through the transscript looking for an explanation for a very particular question..
MC: ".. We continue to solidify our institutional shareholders base and regain the confidence of Wall Street. .." "..Our financial positions has significantly been enhanced through our receipt of $45 million with the UT collaboration agreement. Our $40 million public offering... And we ended 2018 with $72 million in cash.." "..Some of the first ones to expect will be the achievement of our first milestone United Therapeutics. We anticipate this being completed, hopefully by the end of Q1.
We have multiple data publications coming out around Hypoglycemia safety and efficacy. We expect to complete pediatric cohort 2 and progress cohort 3. We expect Brazil
approval sometime during late Q1 or Q2.."
".. we continue to accelerate sales and will continue to make efforts that are in the best interest to shareholders.."
Mike, why did you give away 20% if the shares? Given in how you got us there, it is bad to have the greatest amount of cash and not debt in the current situation!
Regardless what you said, that was NOT in the interest of the shareholders! Still there is no explanation for it! The 40 Million you got for it will be meaningless small very soon.. but any future shareholder value as you call it will only be 80%..
I believe Deerfield not only has their facility as collateral but Afrezza. I think it's preventing MNKD from a partnership. Hopefully they will get rid of DF before ADA2019 and make a big splash at ADA with a new CO-PROMO PARTNER. Afrezza RELAUNCH!!! You heard it here first!!! |
|
|
|
Post by mango on Feb 27, 2019 1:39:21 GMT -5
|
|
